openPR Logo
Press release

Asia Pacific Retractable Needle Safety Syringes Market Research Report Forecast to 2024

08-18-2017 02:32 PM CET | Health & Medicine

Press release from: TMR - Research Reports

Asia Pacific Retractable Needle Safety Syringes Market

Asia Pacific Retractable Needle Safety Syringes Market: Snapshot

A retractable needle safety syringe is fully integrated with safety mechanism, which is designed to withdraw the needle into the barrel of the syringe after the full delivery of a dose. When the liquid is expelled, the operator has to apply additional pressure to the plunger to break the seal and retract the needle into the syringe. Retractable syringes are safe and time-saving and reduce waste volume compared to disposable syringes. Retractable needle syringes are used in several indications such as cancer, diabetes, tuberculosis etc. but highly used in diabetes. According to Asian diabetic prevention initiatives 60% of diabetics in the world lives in Asia. By 2030, without intervention, both China and India combined will have almost half a billion diabetics

Read the Comprehensive Overview of Asia Pacific Retractable Needle Safety Syringes Market: http://www.transparencymarketresearch.com/asia-pacific-retractable-needle-safety-syringes-market.html

Factors such as the rising geriatric population, increasing incidence of chronic ailments, growing awareness among physicians as well as patients, and the demand for advanced treatment modalities have acted in favor of the Asia Pacific retractable needle safety syringes market. With government initiatives aimed at promoting the quality of healthcare and rising medical tourism, Asia Pacific is likely to emerge as a major market for retractable needle safety syringes in the coming years. Also with several countries participating in spreading health awareness alongside international organizations, Asia Pacific will provide an environment conducive to the growth of the retractable needle safety syringes market.

Between 2016 and 2024, the retractable needle safety syringes market is likely to exhibit a CAGR of 8.9% in Asia Pacific. At this pace, the market’s valuation is expected to reach US$467.2 mn by the end of 2024, from US$236.7 mn in 2016.

Manual Retractable Needle Safety Syringes to Hold Leading Market Share

Based on product type, the Asia Pacific retractable safety syringes market is bifurcated into automatic retractable needle safety syringes and manual retractable needle safety syringes market. Of these, the manual retractable needle safety syringes segment held the largest share in the Asia Pacific retractable needle safety syringes market in 2015 in terms of revenue. Through the course of the forecast period, the segment is expected to dominate the market. Factors such as affordability of the product will support the growth of the manual retractable needle safety syringes segment.

Manual retractable needle safety syringes market is followed by automated retractable needle safety syringes segment. The factors such as ease of use, growing acceptance level will create large opportunity for automated retractable needle safety syringes market. In end-users segment hospital sector growing at a CAGR of 9.5%. Factors such as developed healthcare infrastructure, increasing insurance coverage and technologically advanced therapeutic procedures will add value to the hospital segment in Asia Pacific.

Japan to Remain Leading Market for Retractable Needle Safety Syringes in Asia Pacific

Country-wise, Japan emerged as the dominant market for retractable needle safety syringes in Asia Pacific. Exhibiting a robust 9.1% CAGR, the nation is predicted to remain dominant through the course of the forecast period. Consumers in Japan are more aware, which has resulted in the earlier adoption of novel therapeutics and medical practices. This, coupled with the rising geriatric population, high willingness to spend on advanced treatments, and the rising incidence of diabetes have creates a fertile terrain for the market to flourish in Japan.

Besides this, opportunities are likely to bolster in the India market as well. By 2024, the nation will exhibit robust growth benefiting from the increasing awareness among citizens, rising demand for advanced safety syringes, and the increasing incidence of chronic ailments. Additionally, the Indian government has increased their healthcare spending, which is expected to have a positive impact on the retractable needle safety syringes market. Overall the countries in ASEAN will offer lucrative prospects for the retractable needle safety syringes market on account of the rising demand for advanced healthcare, which is further bolstered by the population growth rate.

Request for the Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=24083

Some of the major players operating in the Asia Pacific retractable needle safety syringes market include Retractable Technologies, Inc., Axel Bio Corporation, Sol-Millennium, DMC Medical Limited, UltiMed, Inc., Medigard Limited , Becton, Dickinson and Company ,Medtronic plc , Smiths Medical , Globe Medical Tech, Inc. , Medigard Limited dominated the market in 2015. This is due to various business growth strategies adopted by the companies to have strong presence in the markets.

About TMR

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Asia Pacific Retractable Needle Safety Syringes Market Research Report Forecast to 2024 here

News-ID: 674923 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Asia

Asia Private Equity Firm, Asia Private Equity Management, Asia Private Equity Se …
The private equity market in China has been rapidly growing in recent years. Private equity (PE) refers to the purchase of shares in a company that are not publicly traded on a stock exchange. PE firms typically target companies that are undervalued or in need of capital for growth, and aim to improve the company's operations and financial performance before selling it at a higher value. https://boomingfaucet.com/ Asia Private Equity Consulting E-mail:nolan@pandacuads.com In China,
South East Asia Business Jet Market And Top Key Players are Asia Corporate Jet, …
By 2022, the South East Asia Business Jet Markets estimated to reach US$ XX Mn, up from US$ XX Mn in 2016, growing at a CAGR of XX% during the forecast period. The Global Business Jet Market, currently at 21 million USD, contributes the highest share in the market and is poised to grow at the fastest rate in the future. The three broad categories of business jets are Small,
LIXIL Asia Presents Asia Pacific Property Awards
Through its power brands GROHE and American Standard, LIXIL Asia signs a three-year deal to become the Headline Sponsor of the Asia Pacific Property Awards from 2019 until 2022. 23rd January 2019: The International Property Awards, first established in 1993, are open to residential and commercial property professionals from around the globe. They celebrate the highest levels of achievement by companies operating within the architecture, interior design, real estate and property
PEOPLEWAVE WINS ASIA TECH PODCAST PITCHDECK ASIA 2019 AWARDS
15 January 2019, Singapore – Peoplewave, Asia’s leading data-driven HR technology company, won the Asia Tech Podcast (ATP) Pitchdeck Asia 2019 Awards, being awarded “Startup Most Likely to Succeed in 2019". The 2019 Pitchdeck Asia Awards is an opportunity for the Asian Startup Ecosystem to shine a spotlight on some of its best startups. The awards were decided by a public vote. More than 7,200 votes were cast by registered LinkedIn
Undersea Defence Technology Asia, UDT Asia 2011
Latest Military Diving Technologies featured in UDT Asia Equipping Asia’s navies with the latest diving technology for asymmetric warfare and operations SINGAPORE, 17 October 2011 - Naval diving and underwater special operations is a field that is seeing increased attention and investment amongst navies in Asia. Units such as the Indonesian Navy‟s KOPASKA, the Republic of Singapore Navy‟s Naval Diving Unit (NDU), the Royal Malaysian Navy‟s PASKAL are increasingly utilising specialised equipment for conducting
Asia Diligence – Specialist Investigative Due Diligence for Asia & Beyond
Asia Diligence today announced the opening of its European Customer Services office in the United Kingdom. The office is to be managed by Steve Fowler and will focus on providing services to Asia Diligence’s European customers. Asia Diligence is also planning to open a US office in the near future, which will provide customer service to its US and North American clients. Asked to comment on the move, Luke Palmer, the